Society for Vascular Medicine
Medications included semaglutide (AOM and ADM, oral and injectable), liraglutide (AOM and ADM), exenatide (ADM), lixisenatide (ADM), tirzepatide (AOM and ADM), and dulaglutide (ADM)
Some clients pair them with EMS and cavitation for enhanced body contouring, while others use them as a finishing touch after weight loss therapy
After 12 months of treatment, compared with those on semaglutide alone, women who were taking both MHT and semaglutide: showed an improved weight loss response achieved about 30% more total body weight loss The reasons for this association are unknown, though the authors propose that it may be due to MHT improving other quality of life measures
Kroon, MD, PhD, neonatologist, Erasmus Medical Center Rotterdam, Sophia Childrens Hospital, Department of Pediatrics, Division of Neonatology, Rotterdam, the Netherlands